MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.220
-0.060 (-4.69%)
At close: Aug 28, 2026, 4:00 PM EDT
1.213
-0.008 (-0.61%)
After-hours: Aug 28, 2026, 7:30 PM EDT
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $125.91 million as of August 28, 2026. Its market cap has decreased by -15.64% in one year.
Market Cap
125.91M
Enterprise Value
37.47M
1-Year Change
-15.64%
Ranking
Category
Stock Price
$1.22
ChartMarket Cap Chart
Since the IPO on July 30, 2021, MaxCyte's market cap has decreased from $897.06M to $125.91M, a decrease of -85.96%. That is a compound annual growth rate of -32.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 125.91M | -23.85% |
| Dec 31, 2025 | 165.34M | -62.39% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 14.96% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lucid Diagnostics | 189.31M |
| Quantum-Si incorporated | 170.73M |
| Inogen | 145.96M |
| Owlet | 145.82M |
| Apyx Medical | 129.74M |
| Quanterix | 124.85M |
| Pulmonx | 102.22M |
| LENSAR | 101.97M |